32 results
SC TO-C
EX-10.1
INVA
Innoviva Inc
11 Jul 22
Information about tender offer
3:46pm
, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter … genders; and the neuter gender shall include masculine and feminine genders.
(b) The parties hereto agree that any rule of construction to the effect
SC TO-C
EX-2.1
INVA
Innoviva Inc
11 Jul 22
Information about tender offer
3:46pm
the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders … ; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders.
(b) The parties
8-K
EX-10.1
INVA
Innoviva Inc
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter … genders; and the neuter gender shall include masculine and feminine genders.
(b) The parties hereto agree that any rule of construction to the effect
8-K
EX-2.1
9eja 4zg2nzfknhzlssi
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
425
wvh2h03tzcqszd7uz0
11 Jul 22
Business combination disclosure
7:38am
SC TO-C
EX-2.1
lgz6r5qhla 53
23 May 22
Information about tender offer
8:53pm
8-K
EX-2.1
yd774luv8kn34qj eoh
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-10.2
zxajvhnhl46y0upmw
14 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-10.5
ypoqpm
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.1
wikgfjga
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.4
atsy 58k4ppqdeq8x7ck
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.3
1urh qnf6
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-4.4
q3r0cg
25 Jan 13
Theravance Announces Closing of Public Offering of $287.5 Million of Convertible Subordinated Notes
12:00am
S-3ASR
EX-4.4
gfs5gx2o 06v5
16 Jan 13
Automatic shelf registration
12:00am
8-K
EX-99.6
3nfw8b
4 Sep 12
Other Events
12:00am
8-K
EX-99.11
ell10n6tmol87sk7om
4 Sep 12
Other Events
12:00am
8-K
EX-99.13
n9bk1ne6sder
4 Sep 12
Other Events
12:00am